| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $471.8M | -8.3% | -57.6% |
| Cost of Revenue | $238.1M | — | -63.0% |
| Gross Profit | $233.7M | -0.3% | -50.1% |
| R&D Expense | $58.2M | — | -30.6% |
| SG&A Expense | $109.2M | — | -43.8% |
| Operating Income | $23.7M | +917.2% | -82.3% |
| Pre-tax Income | $46.5M | — | +204.7% |
| Income Tax | -$185.2M | — | +44.6% |
| Net Income | $5.51B | +305.1% | +602.6% |
| EPS (Basic) | $24.45 | — | +588.7% |
| EPS (Diluted) | $23.15 | — | +703.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.51B | +232.7% | +408.8% |
| Accounts Receivable | $377.4M | +7.7% | -55.3% |
| Inventory | $336.9M | +8.5% | -56.0% |
| Current Assets | $3.32B | -42.7% | +44.7% |
| Total Assets | $5.44B | -41.9% | -27.5% |
| Current Liabilities | $498.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$226.6M | — | -21.2% |
| Capital Expenditures | $2.2M | — | -85.8% |
| Investing Cash Flow | $10.54B | — | +422.0% |
| Financing Cash Flow | -$8.67B | — | -332.2% |
| Free Cash Flow | -$228.8M | — | -13.0% |
| -52.5% |
| Long-term Debt | $0 | -100.0% | -100.0% |
| Total Liabilities | $848.5M | -90.7% | -90.4% |
| Stockholders' Equity | $4.59B | +557.6% | +280.3% |